| Year |
Citation |
Score |
| 2023 |
Pai G, Roohollahi K, Rockx D, de Jong Y, Stoepker C, Pennings C, Rooimans M, Vriend L, Piersma S, Jimenez CR, De Menezes RX, Van Beusechem VW, Brakenhoff RH, Te Riele H, Wolthuis RMF, et al. Genome-wide siRNA screens identify RBBP9 function as a potential target in Fanconi anaemia-deficient head-and-neck squamous cell carcinoma. Communications Biology. 6: 37. PMID 36639418 DOI: 10.1038/s42003-022-04389-3 |
0.4 |
|
| 2022 |
Pieters W, Hugenholtz F, Kos K, Cammeraat M, Moliej TC, Kaldenbach D, Klarenbeek S, Davids M, Drost L, de Konink C, Delzenne-Goette E, de Visser KE, Te Riele H. Pro-mutagenic effects of the gut microbiota in a Lynch syndrome mouse model. Gut Microbes. 14: 2035660. PMID 35188867 DOI: 10.1080/19490976.2022.2035660 |
0.404 |
|
| 2021 |
Will Castro LSEP, Pieters W, Alemdehy MF, Aslam MA, Buoninfante OA, Raaijmakers JA, Pilzecker B, van den Berk PCM, Te Riele H, Medema RH, Pedrosa RC, Jacobs H. The Widely Used Antihelmintic Drug Albendazole is a Potent Inducer of Loss of Heterozygosity. Frontiers in Pharmacology. 12: 596535. PMID 33679394 DOI: 10.3389/fphar.2021.596535 |
0.308 |
|
| 2020 |
van Ravesteyn TW, Arranz Dols M, Pieters W, Dekker M, Te Riele H. Extensive trimming of short single-stranded DNA oligonucleotides during replication-coupled gene editing in mammalian cells. Plos Genetics. 16: e1009041. PMID 33119594 DOI: 10.1371/journal.pgen.1009041 |
0.308 |
|
| 2020 |
van Schie JJM, Faramarz A, Balk JA, Stewart GS, Cantelli E, Oostra AB, Rooimans MA, Parish JL, de Almeida Estéves C, Dumic K, Barisic I, Diderich KEM, van Slegtenhorst MA, Mahtab M, Pisani FM, ... Te Riele H, et al. Warsaw Breakage Syndrome associated DDX11 helicase resolves G-quadruplex structures to support sister chromatid cohesion. Nature Communications. 11: 4287. PMID 32855419 DOI: 10.1038/s41467-020-18066-8 |
0.342 |
|
| 2019 |
van de Vrugt HJ, Harmsen T, Riepsaame J, Alexantya G, van Mil SE, de Vries Y, Bin Ali R, Huijbers IJ, Dorsman JC, Wolthuis RMF, Te Riele H. Effective CRISPR/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair. Scientific Reports. 9: 768. PMID 30683899 DOI: 10.1038/s41598-018-36506-w |
0.393 |
|
| 2017 |
Houlleberghs H, Goverde A, Lusseveld J, Dekker M, Bruno MJ, Menko FH, Mensenkamp AR, Spaander MCW, Wagner A, Hofstra RMW, Te Riele H. Suspected Lynch syndrome associated MSH6 variants: A functional assay to determine their pathogenicity. Plos Genetics. 13: e1006765. PMID 28531214 DOI: 10.1371/journal.pgen.1006765 |
0.36 |
|
| 2017 |
Wielders E, Delzenne-Goette E, Dekker R, van der Valk M, Te Riele H. Truncation of the MSH2 C-terminal 60 amino acids disrupts effective DNA mismatch repair and is causative for Lynch syndrome. Familial Cancer. 16: 221-229. PMID 27873144 DOI: 10.1007/s10689-016-9945-x |
0.383 |
|
| 2014 |
Wojciechowicz K, Cantelli E, Van Gerwen B, Plug M, Van Der Wal A, Delzenne-Goette E, Song JY, De Vries S, Dekker M, Te Riele H. Temozolomide increases the number of mismatch repair-deficient intestinal crypts and accelerates tumorigenesis in a mouse model of Lynch syndrome. Gastroenterology. 147: 1064-72.e5. PMID 25088490 DOI: 10.1053/j.gastro.2014.07.052 |
0.317 |
|
| 2013 |
Wielders EA, Houlleberghs H, Isik G, te Riele H. Functional analysis in mouse embryonic stem cells reveals wild-type activity for three MSH6 variants found in suspected Lynch syndrome patients. Plos One. 8: e74766. PMID 24040339 DOI: 10.1371/journal.pone.0074766 |
0.358 |
|
| 2013 |
Bakker ST, de Winter JP, te Riele H. Learning from a paradox: recent insights into Fanconi anaemia through studying mouse models. Disease Models & Mechanisms. 6: 40-7. PMID 23268537 DOI: 10.1242/dmm.009795 |
0.685 |
|
| 2012 |
Ezzatizadeh V, Pinto RM, Sandi C, Sandi M, Al-Mahdawi S, Te Riele H, Pook MA. The mismatch repair system protects against intergenerational GAA repeat instability in a Friedreich ataxia mouse model. Neurobiology of Disease. 46: 165-71. PMID 22289650 DOI: 10.1016/j.nbd.2012.01.002 |
0.356 |
|
| 2012 |
Bakker ST, van de Vrugt HJ, Visser JA, Delzenne-Goette E, van der Wal A, Berns MA, van de Ven M, Oostra AB, de Vries S, Kramer P, Arwert F, van der Valk M, de Winter JP, te Riele H. Fancf-deficient mice are prone to develop ovarian tumours. The Journal of Pathology. 226: 28-39. PMID 21915857 DOI: 10.1002/path.2992 |
0.683 |
|
| 2011 |
van de Vrugt HJ, Koomen M, Bakker S, Berns MA, Cheng NC, van der Valk MA, de Vries Y, Rooimans MA, Oostra AB, Hoatlin ME, Te Riele H, Joenje H, Arwert F. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg. Dna Repair. 10: 1252-61. PMID 22036606 DOI: 10.1016/J.Dnarep.2011.09.015 |
0.674 |
|
| 2010 |
Chalastanis A, Penard-Lacronique V, Svrcek M, Defaweux V, Antoine N, Buhard O, Dumont S, Fabiani B, Renault I, Tubacher E, Fléjou JF, Te Riele H, Duval A, Muleris M. Azathioprine-induced carcinogenesis in mice according to Msh2 genotype. Journal of the National Cancer Institute. 102: 1731-40. PMID 20923998 DOI: 10.1093/jnci/djq389 |
0.35 |
|
| 2010 |
Aarts M, te Riele H. Subtle gene modification in mouse ES cells: evidence for incorporation of unmodified oligonucleotides without induction of DNA damage. Nucleic Acids Research. 38: 6956-67. PMID 20601408 DOI: 10.1093/nar/gkq589 |
0.319 |
|
| 2010 |
van Harn T, Foijer F, van Vugt M, Banerjee R, Yang F, Oostra A, Joenje H, te Riele H. Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling. Genes & Development. 24: 1377-88. PMID 20551164 DOI: 10.1101/gad.580710 |
0.34 |
|
| 2010 |
Aarts M, te Riele H. Parameters of oligonucleotide-mediated gene modification in mouse ES cells. Journal of Cellular and Molecular Medicine. 14: 1657-67. PMID 19627401 DOI: 10.1111/j.1582-4934.2009.00847.x |
0.344 |
|
| 2009 |
Bakker ST, van de Vrugt HJ, Rooimans MA, Oostra AB, Steltenpool J, Delzenne-Goette E, van der Wal A, van der Valk M, Joenje H, te Riele H, de Winter JP. Fancm-deficient mice reveal unique features of Fanconi anemia complementation group M. Human Molecular Genetics. 18: 3484-95. PMID 19561169 DOI: 10.1093/hmg/ddp297 |
0.68 |
|
| 2009 |
Ferrás C, Oude Vrielink JA, Verspuy JW, te Riele H, Tsaalbi-Shtylik A, de Wind N. Abrogation of microsatellite-instable tumors using a highly selective suicide gene/prodrug combination. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1373-80. PMID 19471249 DOI: 10.1038/mt.2009.114 |
0.339 |
|
| 2007 |
Foijer F, Delzenne-Goette E, Dekker M, Te Riele H. In vivo significance of the G2 restriction point. Cancer Research. 67: 9244-7. PMID 17909031 DOI: 10.1158/0008-5472.CAN-07-1650 |
0.31 |
|
| 2006 |
Aarts M, Dekker M, de Vries S, van der Wal A, te Riele H. Generation of a mouse mutant by oligonucleotide-mediated gene modification in ES cells. Nucleic Acids Research. 34: e147. PMID 17142234 DOI: 10.1093/nar/gkl896 |
0.363 |
|
| 2006 |
Foijer F, te Riele H. Check, double check: the G2 barrier to cancer. Cell Cycle (Georgetown, Tex.). 5: 831-6. PMID 16627998 DOI: 10.4161/cc.5.8.2687 |
0.338 |
|
| 2006 |
Foiry L, Dong L, Savouret C, Hubert L, te Riele H, Junien C, Gourdon G. Msh3 is a limiting factor in the formation of intergenerational CTG expansions in DM1 transgenic mice. Human Genetics. 119: 520-6. PMID 16552576 DOI: 10.1007/s00439-006-0164-7 |
0.514 |
|
| 2006 |
Zienolddiny S, Ryberg D, Svendsrud DH, Eilertsen E, Skaug V, Hewer A, Phillips DH, te Riele H, Haugen A. Msh2 deficiency increases susceptibility to benzo[a]pyrene-induced lymphomagenesis. International Journal of Cancer. 118: 2899-902. PMID 16381012 DOI: 10.1002/ijc.21686 |
0.487 |
|
| 2004 |
Dannenberg JH, Schuijff L, Dekker M, van der Valk M, te Riele H. Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130. Genes & Development. 18: 2952-62. PMID 15574596 DOI: 10.1101/gad.322004 |
0.334 |
|
| 2004 |
Savouret C, Garcia-Cordier C, Megret J, te Riele H, Junien C, Gourdon G. MSH2-dependent germinal CTG repeat expansions are produced continuously in spermatogonia from DM1 transgenic mice. Molecular and Cellular Biology. 24: 629-37. PMID 14701736 DOI: 10.1128/mcb.24.2.629-637.2004 |
0.459 |
|
| 2003 |
Savouret C, Brisson E, Essers J, Kanaar R, Pastink A, te Riele H, Junien C, Gourdon G. CTG repeat instability and size variation timing in DNA repair-deficient mice. The Embo Journal. 22: 2264-73. PMID 12727892 DOI: 10.1093/emboj/cdg202 |
0.489 |
|
| 2003 |
Claij N, van der Wal A, Dekker M, Jansen L, te Riele H. DNA mismatch repair deficiency stimulates N-ethyl-N-nitrosourea-induced mutagenesis and lymphomagenesis. Cancer Research. 63: 2062-6. PMID 12727820 |
0.441 |
|
| 2003 |
Wheeler VC, Lebel LA, Vrbanac V, Teed A, te Riele H, MacDonald ME. Mismatch repair gene Msh2 modifies the timing of early disease in Hdh(Q111) striatum. Human Molecular Genetics. 12: 273-81. PMID 12554681 DOI: 10.1093/Hmg/Ddg056 |
0.373 |
|
| 2002 |
Yoshino M, Nakatsu Y, te Riele H, Hirota S, Kitamura Y, Tanaka K. Additive roles of XPA and MSH2 genes in UVB-induced skin tumorigenesis in mice. Dna Repair. 1: 935-40. PMID 12531021 DOI: 10.1016/s1568-7864(02)00144-1 |
0.519 |
|
| 2002 |
Meira LB, Cheo DL, Reis AM, Claij N, Burns DK, te Riele H, Friedberg EC. Mice defective in the mismatch repair gene Msh2 show increased predisposition to UVB radiation-induced skin cancer. Dna Repair. 1: 929-34. PMID 12531020 DOI: 10.1016/S1568-7864(02)00143-X |
0.484 |
|
| 2002 |
Toft NJ, Curtis LJ, Sansom OJ, Leitch AL, Wyllie AH, te Riele H, Arends MJ, Clarke AR. Heterozygosity for p53 promotes microsatellite instability and tumorigenesis on a Msh2 deficient background. Oncogene. 21: 6299-306. PMID 12214270 DOI: 10.1038/sj.onc.1205727 |
0.311 |
|
| 2002 |
Vooijs M, Te Riele H, Van der Valk M, Berns A. Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells Oncogene. 21: 4635-4645. PMID 12096340 DOI: 10.1038/sj.onc.1205575 |
0.38 |
|
| 2002 |
Kohonen-Corish MR, Daniel JJ, te Riele H, Buffinton GD, Dahlstrom JE. Susceptibility of Msh2-deficient mice to inflammation-associated colorectal tumors. Cancer Research. 62: 2092-7. PMID 11929830 |
0.481 |
|
| 2002 |
van den Broek WJ, Nelen MR, Wansink DG, Coerwinkel MM, te Riele H, Groenen PJ, Wieringa B. Somatic expansion behaviour of the (CTG)n repeat in myotonic dystrophy knock-in mice is differentially affected by Msh3 and Msh6 mismatch-repair proteins. Human Molecular Genetics. 11: 191-8. PMID 11809728 DOI: 10.1093/Hmg/11.2.191 |
0.41 |
|
| Show low-probability matches. |
